507 related articles for article (PubMed ID: 22161228)
21. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
[TBL] [Abstract][Full Text] [Related]
22. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
[TBL] [Abstract][Full Text] [Related]
23. 11C-Methionine positron emission tomography for preoperative evaluation of suggestive low-grade gliomas.
Gumprecht H; Grosu AL; Souvatsoglou M; Dzewas B; Weber WA; Lumenta CB
Zentralbl Neurochir; 2007 Feb; 68(1):19-23. PubMed ID: 17487804
[TBL] [Abstract][Full Text] [Related]
24. L-(methyl-11C) methionine positron emission tomography for target delineation in resected high-grade gliomas before radiotherapy.
Grosu AL; Weber WA; Riedel E; Jeremic B; Nieder C; Franz M; Gumprecht H; Jaeger R; Schwaiger M; Molls M
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):64-74. PubMed ID: 16111573
[TBL] [Abstract][Full Text] [Related]
25. 13N-Ammonia PET/CT for detection of recurrent glioma: a prospective comparison with contrast-enhanced MRI.
Khangembam BC; Sharma P; Karunanithi S; Singhal A; Das CJ; Kumar P; Julka PK; Bandopadhyaya GP; Kumar R; Malhotra A; Bal C
Nucl Med Commun; 2013 Nov; 34(11):1046-54. PubMed ID: 24025920
[TBL] [Abstract][Full Text] [Related]
26. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases.
Grosu AL; Astner ST; Riedel E; Nieder C; Wiedenmann N; Heinemann F; Schwaiger M; Molls M; Wester HJ; Weber WA
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1049-58. PubMed ID: 21570201
[TBL] [Abstract][Full Text] [Related]
27. Multimodality assessment of brain tumors and tumor recurrence.
Heiss WD; Raab P; Lanfermann H
J Nucl Med; 2011 Oct; 52(10):1585-600. PubMed ID: 21840931
[TBL] [Abstract][Full Text] [Related]
28. Clinical applications of PET in brain tumors.
Chen W
J Nucl Med; 2007 Sep; 48(9):1468-81. PubMed ID: 17704239
[TBL] [Abstract][Full Text] [Related]
29. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
[TBL] [Abstract][Full Text] [Related]
30. Assessment of clinical usefulness of 131I alpha-methyl-tyrosine and fused SPECT/MRI imaging for diagnostics of recurrent cerebral gliomas.
Górska-Chrzastek M; Grzelak P; Bieńkiewicz M; Tybor K; Zakrzewska E; Mikołajczak R; Stefańczyk L; Kuśmierek J
Nucl Med Rev Cent East Eur; 2004; 7(2):135-41. PubMed ID: 15968600
[TBL] [Abstract][Full Text] [Related]
31. Radiation treatment planning in brain tumours: potential impact of 3-O-methyl-6-[(18)F]fluoro-L-DOPA and PET.
Alheit H; Oehme L; Winkler C; Füchtner F; Hoepping A; Grabowski J; Kotzerke J; Beuthien-Baumann B
Nuklearmedizin; 2008; 47(5):200-4. PubMed ID: 18852926
[TBL] [Abstract][Full Text] [Related]
32. The use of multiparametric 18F-fluoro-L-3,4-dihydroxy-phenylalanine PET/MRI in post-therapy assessment of patients with gliomas.
Fraioli F; Shankar A; Hyare H; Ferrazzoli V; Militano V; Samandouras G; Mankad K; Solda F; Zaccagna F; Mehdi E; Lyasheva M; Bomanji J; Novruzov F
Nucl Med Commun; 2020 Jun; 41(6):517-525. PubMed ID: 32282634
[TBL] [Abstract][Full Text] [Related]
33. Amino Acid Tracer PET MRI in Glioma Management: What a Neuroradiologist Needs to Know.
Soni N; Ora M; Jena A; Rana P; Mangla R; Ellika S; Almast J; Puri S; Meyers SP
AJNR Am J Neuroradiol; 2023 Mar; 44(3):236-246. PubMed ID: 36657945
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive grading of brain tumours using dynamic amino acid PET imaging: does it work for 11C-methionine?
Moulin-Romsée G; D'Hondt E; de Groot T; Goffin J; Sciot R; Mortelmans L; Menten J; Bormans G; Van Laere K
Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2082-7. PubMed ID: 17763978
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of positron emission tomographic studies for gliomas.
Miyake K; Ogawa D; Okada M; Hatakeyama T; Tamiya T
Neurol Med Chir (Tokyo); 2016 Jul; 56(7):396-408. PubMed ID: 27250577
[TBL] [Abstract][Full Text] [Related]
36. Brain tumors.
Goldman S; Pirotte BJ
Methods Mol Biol; 2011; 727():291-315. PubMed ID: 21331940
[TBL] [Abstract][Full Text] [Related]
37. Advances in Magnetic Resonance Imaging and Positron Emission Tomography Imaging for Grading and Molecular Characterization of Glioma.
Chung C; Metser U; Ménard C
Semin Radiat Oncol; 2015 Jul; 25(3):164-71. PubMed ID: 26050586
[TBL] [Abstract][Full Text] [Related]
38. Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas.
Albert NL; Weller M; Suchorska B; Galldiks N; Soffietti R; Kim MM; la Fougère C; Pope W; Law I; Arbizu J; Chamberlain MC; Vogelbaum M; Ellingson BM; Tonn JC
Neuro Oncol; 2016 Sep; 18(9):1199-208. PubMed ID: 27106405
[TBL] [Abstract][Full Text] [Related]
39. Advances in Magnetic Resonance and Positron Emission Tomography Imaging: Assessing Response in the Treatment of Low-Grade Glioma.
Kim MM; Lawrence TS; Cao Y
Semin Radiat Oncol; 2015 Jul; 25(3):172-80. PubMed ID: 26050587
[TBL] [Abstract][Full Text] [Related]
40. F-18 FDG PET-CT in patients with recurrent glioma: comparison with contrast enhanced MRI.
Santra A; Kumar R; Sharma P; Bal C; Kumar A; Julka PK; Malhotra A
Eur J Radiol; 2012 Mar; 81(3):508-13. PubMed ID: 21353420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
